Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Docetaxel and Cisplatin in Metastatic Salivary Gland Cancer
NCT05008237Phase 2Unknown
- Sponsor
- Samsung Medical Center
- Start
- May 2014
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in salivary gland cancer (SGC), sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
docetaxel
03
Conditions
salivary gland cancer (SGC)
Beyond the preview
Go deeper on NCT05008237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05008237.